Resultado de búsqueda
James P. Allison (7 de agosto de 1948) es un inmunólogo estadounidense. Ocupa la cátedra de Inmunología y es el director ejecutivo de la plataforma de inmunoterapia en el M. D. Anderson Cancer Center. Sus descubrimientos se orientan hacia nuevos tratamientos para los tipos de cáncer más letales en humanos.
Dr. James Allison is Regental Professor and Chair of the Department of Immunology, the Olga Keith Wiess Distinguished University Chair for Cancer Research, Director of the Parker Institute for Cancer Research, Executive Director of the Immunotherapy Platform, and Director of the James P. Allison Institute at MD Anderson Cancer Center.
James Patrick Allison (born August 7, 1948) is an American immunologist and Nobel laureate who holds the position of professor and chair of immunology and executive director of immunotherapy platform at the MD Anderson Cancer Center in Houston, Texas.
James Allison is an American immunologist who discovered how to inhibit negative immune regulation and treat cancer. He shared the Nobel Prize with Tasuku Honjo for their groundbreaking work on cancer therapy by immune checkpoint blockade.
1 de oct. de 2018 · James P. Allison and Tasuku Honjo. for their discovery of cancer therapy by inhibition of negative immune regulation. SUMMARY. Cancer kills millions of people every year and is one of humanity’s greatest health challenges.
The Nobel Prize in Physiology or Medicine 2018 was awarded jointly to James P. Allison and Tasuku Honjo "for their discovery of cancer therapy by inhibition of negative immune regulation"
18 de abr. de 2014 · Learn about the Nobel Prize-winning immunologist who discovered the T cell brakes and pioneered cancer immunotherapy. Find out how he studies T cells, identifies targets, and treats patients with checkpoint blockade antibodies.
